Ⓐ
PeptiBrief
Peptide · Peptide medicine

Tirzepatide

Research peptide
Aliases · Mounjaro · Zepbound

Tirzepatide is a regulated peptide medicine with established evidence in defined indications.

Human
2/5
Animal
0/5
In-vitro
0/5
Safety
2/5
Last reviewed · 7/12/2026
Compare with another peptide →
Last reviewed7/12/2026
Evidence statusEarly entry
Published references0
Trust signal panel
Evidence & safety
  • Human evidence
    n/a
  • Animal evidence
    n/a
  • Mechanistic
    n/a
  • Safety knowledge
    n/a
  • Editorial confidence
    5/5
View in knowledge graph →See this peptide connected to conditions & mechanisms
01

Evidence Snapshot

Evidence snapshot · 1 verified ref
Overall
2/5Emerging / preliminary
Human
2/5Some human clinical evidence
Animal
0/5None identified
In-vitro
0/5None identified
Safety
2/5Partially characterised safety
02

Scientific identity

Molecular formula
C225H348N48O68
Molecular weight
4813.45 g/mol
Peptide family
Clinical peptide therapeutic
Entity class
Peptide medicine
Alternative names
MounjaroZepbound
Discovery history

Tirzepatide entered research, clinical or commercial use through investigation of its proposed biological, cosmetic or therapeutic activity.

02

Proposed Mechanisms

03

Reported / Studied Uses

04

Human Evidence

Human clinical evidence supports approved uses of defined formulations.

05

Animal Evidence

Preclinical evidence supports the established pharmacology.

Species translation to humans is uncertain.
06

Safety & Unknowns

prescription-onlygastrointestinal-effectsboxed-warning-uspregnancy-avoidancecounterfeit-riskprescription-medicineindication-specificmedical-supervision
Adverse effects, contraindications and monitoring requirements depend on the approved formulation and indication.
07

Regulatory Status

CountryStatusNotes
08

Community Observations

No approved community reports yet. Submit one. Aggregate data is observational only.
09

References

  • No verified references linked yet. Editors will add primary sources.
10

Full Disclaimer

This page is for educational information only. It does not constitute medical advice, diagnosis, treatment, dosing guidance, or a recommendation to use any peptide, medicine or research chemical. Many peptides discussed on Atlas are not approved for human use in most jurisdictions and may have limited or unknown long-term safety data.

Community observations shown on this page are anonymised, moderated and observational only. They do not establish safety or effectiveness.

Always consult a qualified healthcare professional before making decisions about your health. See medical disclaimer and methodology.

↳

Explore further

from the knowledge graph
Advertise here — support independent evidence →
ImportantPeptiBrief is an educational information platform. It does not diagnose, prescribe, sell peptides, recommend dosing, encourage self-experimentation or replace qualified medical care. Published scientific evidence is kept separate from community observations and uncertainty.